Abstract
Introduction: Military soldiers comprised 1,195 million United States active-duty members and 778,000 reserve members in 9/2021. Soldiers are often exposed to drastic climates, environments, and living conditions which may make them more susceptible to cutaneous diseases.
Methods: A PubMed search of studies published between 1/1/2002 – 8/30/2022, using MeSH terms: ((("Military Personnel"[Majr]) OR "Military Hygiene"[Majr])) OR "Military Medicine"[Majr]) AND "Skin Diseases"[Majr]), the reference lists of select articles, and other applicable sources were reviewed to identify articles on skin conditions affecting military soldiers and treatment options.
Discussion: In this article, we review skin conditions that affect military soldiers in both the deployed and non-deployed settings including infectious diseases, arthropod associated diseases, sexually transmitted infections, ultraviolet radiation related skin disease, acne, diseases of hair and hair follicles, dermatitis, onychocryptosis, and conditions caused by extreme weather conditions and occupational exposures. We also discuss treatment options and prevention methods as they relate to military settings.
Conclusion: Dermatological conditions can considerably impact soldiers’ wellbeing and military performance, often lead to evacuation of military personnel, and are associated with high financial costs. Cutaneous disease is one of most common reasons for soldiers to seek medical care and may cause significant morbidity. Serving in the military often impacts and limits treatment options.
Key messages
Military soldiers are a unique population exposed to crowded living conditions, reduced opportunity for personal hygiene, environmental contamination, strict grooming practices, and skin injury which may contribute to infectious and arthropod associated skin, hair, and nail diseases in soldiers.
Treatment options for skin diseases that are commonly used in the general population may have implications for military duties that should be considered before treatment initiation in soldiers.
Introduction
Military soldiers are a unique population exposed to crowded living conditions, environmental contamination, skin injury, and temperature extremes, which can make them more susceptible to dermatologic disease [Citation1–3]. The military represents a substantial population, with 1195 million United States (US) active-duty service members and 778,000 reserve members in 9/2021 [Citation4]. Skin diseases often lead to evacuation of military personnel from combat theater and affect soldier training and morale [Citation5,Citation6]. Cutaneous disease related disruptions in the military not only hinder military operations but are also associated with high financial costs. In a study on teledermatology consults of deployed US soldiers in Iraq 1/2005–1/2009, the cost of evacuating soldiers back to the US was estimated at $562,380 and the cost of in-person dermatology evaluations in Iraq was $416,000 [Citation7]. Challenges of treating skin conditions in deployed soldiers include slow turnaround time for pathology specimens, lack of access to dermatological care, and arranging follow up care [Citation8].
While mortality from skin disease in soldiers is low, dermatologic conditions in the military setting comprise a large proportion of soldier morbidity. In a review of skin conditions in military peacekeeping operations, military physician visits for skin conditions ranged from 9.3% (during the Gulf war) to 25.2% (in an East Timor deployment) [Citation9]. In US soldiers specifically, 10% (429,837 cases) of deployed setting medical diagnoses 2008–2015, were dermatological [Citation10].
The climate, environment, and living conditions in which the soldiers serve may affect their spectrum of skin diseases ( and ) [Citation5,Citation6,Citation9,Citation11,Citation12]. For example, outpatient visits for cutaneous disease during World War II was 15–25% in temperate climates, and 75% in tropical climates [Citation13–15]. Given the large percentage of dermatology consults in deployed soldiers, impact on soldiers’ wellbeing and ability to perform, and associated costs, US military dermatologists have recommended that dermatologists’ deployment as theater consultants would help reduce costs and lost workdays due to cutaneous disease [Citation13]. Prior reviews of dermatoses affecting military populations have focused solely on military operations [Citation9] or deployed settings in a specific military population [Citation16]. However, a review discussing dermatological conditions in both deployed and base settings inclusive of worldwide militaries is lacking. In this review, we highlight common skin disorders that affect military soldiers of different militaries in both deployed and base settings, challenges they present to military personnel and military operations, and potential solutions.
Methods
A PubMed search was used to identify studies published between 1/1/2002 and 8/30/2022 in English, using MeSH terms search: (((‘Military Personnel’[Majr]) OR ‘Military Hygiene’ [Majr])) OR ‘Military Medicine’ [Majr]) AND ‘Skin Diseases’[Majr]). 312 PubMed results were identified. Article type selection included the following subcategories: Systematic reviews, clinical study, clinical trial, comparative studies, multicenter studies, observational studies, randomized controlled trials, and review articles. Articles evaluating specific treatments, focused non-soldier populations or non-dermatology conditions were excluded. Reviews covering topics sufficiently covered by studies were excluded. The reference list of select publications was used to expand the search. Relevant articles found outside of the primary search methods were evaluated and included and cited in the reference list to supplement discussion. Articles on monkeypox and the Coronavirus disease 2019 (COVID-19) were searched for outside of the primary search method, as to highlight current public health issues ongoing at the time of manuscript drafting.
Discussion
The studies included in this review highlight differences in prevalence of dermatoses in military populations by environmental settings. In studies of deployed soldiers serving in hot and dry climates, dermatitis and eczematous conditions were most common accounting for 13%–38.7% of all skin dermatoses [Citation7,Citation17–20]. Studies of deployed soldiers serving in hot and humid conditions showed the highest prevalence of bacterial (21.2%) and fungal (23.3%) infections being the most common dermatologic conditions () [Citation5,Citation21]. In the non-deployed setting, dermatitis and eczematous conditions accounted for 13.4%–24%, fungal infections accounted for 5%–28%, and acne accounted for 5%–43.7% of all skin conditions () [Citation11,Citation12,Citation22,Citation23].
Infectious diseases
Bacterial skin infections
Bacterial skin infections including those caused by Methicillin-Resistant Staphylococcus aureus (MRSA) are common during military training [Citation24]. Crowded living conditions, reduced opportunity for personal hygiene, environmental contamination, and skin injury contribute to higher rates of skin and soft tissue infections (SSTIs) in military recruits compared to all military personnel [Citation1–3]. In a study of SSTI’s in 772 military trainees serving in a joint base in San Antonino-Lackland, Texas, 10/1/2012–12/31/2014, there were 254 culture positive SSTI cases, of which 43.3% grew MRSA, 26.8% Methicillin-sensitive S. aureus, and 7.2% and 2% grew other gram-negative and gram-positive cocci respectively (16.6% grew usual skin flora and 6.3% had no growth) [Citation24]. A 2012–2014 whole genome sequencing study of US Army Infantry trainees with confirmed MRSA SSTI’s, showed intra- and inter-class transmission of MRSA among military soldiers, suggesting the introduction of multiple strains of MRSA, as well as person to person transmission in military settings [Citation25].
Two surveillance studies of active US military personnel reported over 490 thousand SSTI cases 2013–2020. However, between 2013–2016 and 2016–2020 crude incidence rates decreased from 558.2/10,000 person years (p-yrs) to 352.8/10,000 p-yrs respectively with a shift from ‘other’ SSTI’s (including cellulitis, impetigo, and pyoderma) to cellulitis/abscess as the most common SSTI (). Carbuncles, furuncles and ‘other’ SSTI’s occurred more frequently in Black service members. In the 2013–2016 cohort, incidence rates of carbuncles/furuncles and ‘other’ SSTI’s in Black service members were 37.4 per 10,000 p-yrs and 911.2 per 10,000 p-yrs, respectively, vs. 26 per 10,000 p-yrs and 276 per 10,000 p-yrs, respectively, in the total study population. In the 2016–2020 cohort, incidence rates of carbuncles/furuncles and ‘other’ SSTI’s in Black service members were 27.5 per 10,000 p-yrs and 120.6 per 10,000 p-yrs respectively vs. 18.7 per 10,000 p-yrs and 105.9 per 10,000 p-yrs, respectively, in the total study population. Cellulitis/abscess were more common in White service members. In the 2013–2016 cohort, incidence rates of cellulitis/abscess in White service members were 273.4 per 10,000 p-yrs vs. 256 per 10,000 p-yrs in the total study population. In the 2016–2020 cohort, incidence rates of cellulitis/abscess in White service members were 243.7 per 10,000 p-yrs vs. 227.7 per 10,000 p-yrs in the total study population [Citation3,Citation26]. Incidence of SSTI’s was higher in female vs. male military personnel 2016–2020 (Female SSTI rate of 397.9 vs. 343.9 in males) [Citation26]. There was also a higher proportion of MRSA SSTI cases in female vs. male military trainees serving in a joint base in Texas 2012–2014, (81% in females vs. 58% in males) [Citation24]. A questionnaire-based study of US military personnel mid-deployment 8/2007 − 7/2008, reported that in any branch besides the marines, females had an increased risk of reporting SSTI’s (p = .01), with the army having the largest sample size (95.3% of total study participants) and 6.9% of female army personnel reporting SSTI’s compared to 4.7% for males [Citation27].
Incidence rates of bacterial skin infections during Operation Iraqi Freedom (OIF), and East Timor Deployment, and the Vietnam war were 6%, 15%, and 21.2% of all skin disease diagnoses, respectively () [Citation5,Citation21,Citation28]. East Timor’s and Vietnam’s hot and humid climates, likely provide a favorable environment for the development of bacterial infections [Citation5,Citation21]. In Iraq, bacterial infections presented in all patients as painful abscess on the extremities or back [Citation28]. In East Timor, bacterial infections included superficial folliculitis and pitted keratolysis. Superficial folliculitis often progressed to furuncles, and less often to carbuncles [Citation5].
In a review of SSTIs in the military published in 2013, Lamb et al. recommended hygiene practices, education, and isolation of cases, as strategies to prevent the spread of bacterial infection in the military. Early recognition and treatment were highlighted as key for treating bacterial SSTI’s in military soldiers. For superficial uncomplicated infections, topical agents are generally recommended. However, in deployed settings, systemic antibiotics are recommended due to the barriers of applying topical agents in this environment. If necrotizing fasciitis occurs in soldiers on operations, recommended treatments are linezolid, meropenem, and clindamycin for broad coverage. Military soldiers may be exposed to less common pathogens compared to the general population due to their changing environments. For example, Aeromonas hydrophilia or vibrio species may be responsible for cellulitis from marine-related injuries. Testing for Panton-Valentine Leukocidin S. Aureus and other resistant or unusual pathogens may be considered in soldiers deployed to foreign countries. Methicillin resistance should be considered when treating both uncomplicated and complicated infections [Citation29].
Fungal infections
Dermatophytosis was the most common dermatologic diagnosis in a retrospective study of 429,837 dermatologic diagnoses in deployed US soldiers 2008–2015, accounting for 11.6% of all dermatologic diagnoses, which is higher than the dermatophytosis rate in US civilian non-dermatologist and dermatologist diagnoses (3.9% and 1.8% of the 431,870,000 and 296,100,000 total dermatologic diagnoses, respectively) [Citation10]. Hot and humid environments in some military deployments likely contribute to a higher prevalence of dermatophyte infections (). Fungal skin infections were the most common skin condition in two military cohorts serving in East Timor 1999–2000 and in Singapore 2007–2009, which share similar tropical environments [Citation5,Citation12]. In the East Timor deployment, 45 diagnoses of dermatophyte infections included tinea pedis (38/45), tinea corporis and tinea cruris (6/45), and pityrosporum folliculitis (1/45), with Trichophytum rubrum isolated from 90% culture positive cases [Citation5]. Fungal infections are also a significant cause of morbidity in non-tropical environments. In a Chinese Peacekeeping mission in Lebanon, which has Mediterranean climate conditions, cutaneous mycosis was the second most common diagnosis accounting for 13.3% of the 549 dermatologic diagnoses, with tinea corporis and tinea pedis being the most common types (5.3% and 4.7% of total dermatological diagnoses, respectively) [Citation17].
Tinea pedis may lead to toenail onychomycosis, and secondary infections () [Citation30–32]. The worldwide prevalence of tinea pedis is approximately 15% [Citation33]. In a 17-year surveillance study of the US military 2000–2016, the overall incidence rate of tinea pedis was 84.0 cases per 10,000 p-yrs. The overall incidence rate was 17.4% higher in male vs. female service members (85.9 cases per 10,000 p-yrs vs. 73.1 cases per 10,000 p-yrs, respectively), and Black and Hispanic service members had the highest overall incidence rates (109.9 cases per 10,000 p-yrs and 91.3 cases per 10,000 p-yrs, respectively) [Citation31]. A cross-sectional study of tinea pedis in 223 Israeli soldiers conducted during a 2-month hot and dry summer period that was published in 2005, showed a 60.1% (n = 134/223) clinical prevalence (positive clinical skin examination) and 27.3% (n = 61/223) mycological prevalence (positive cultures) of tinea pedis. Male gender (p = .002), setting of military training (p < .001), and infrequent sock changes (p = .043) were associated with a higher prevalence of tinea pedis on univariate analysis [Citation34]. Another cross-sectional study of tinea pedis in 729 male soldiers and 279 male civilians employed by the Georgian Defense Forces, published in 2021, reported a clinical and mycological prevalence of tinea pedis of 46.4% (n = 340/729) and 24.25% (n = 184/729), respectively, in soldiers and 21.86% and 13.98%, respectively, in civilians. In total, 10.13% (n = 74/729) of soldiers had toenail onychomycosis. History of tinea pedis prior to military service (p = .159), wearing military boots for 14 h every day (p = .105), and using communal showers (p = .074) were associated with a higher prevalence of tinea pedis. Wearing two or more pairs of military boots, which lessens moisture and humidity, was associated with a decreased risk of tinea pedis (p = −0.354) [Citation35]. A Japanese study published in 1995 analyzed the relationship between the interdigital space and tinea pedis in 74 soldiers undergoing specialized training in Texas, USA. Soldiers were divided into 3 groups based on the width of their interdigital spaces (I = wide, II = fairly wide, III = closed). The prevalence of tinea pedis in groups I, II and III was 30% (n = 3) vs. 77% (n = 19) vs. 90% (n = 27), respectively (p < .01), with severity medians of 2.3, 4.3, and 4.2, respectively (Spearman r = 0.12, p < .32) [Citation36], suggesting that smaller interdigital space width conferred greater risk and severity of tinea pedis.
Preventative efforts, such as education on foot and skin health maintenance practices, and administration of topical antifungals may help decrease the incidence of tinea pedis [Citation18,Citation31,Citation36–39]. In a study of 169 Australian troops serving in East Timor 9/27/1999-2/20/2000, all troops were issued preventative foot powder (83% talc, 10% starch and 3% salicylic acid) and topical treatments were used for cases of tinea corporis and tinea cruris [Citation5]. In a review of SSTIs in the military published in 2013, Lamb et al. recommended treatment with topical antifungals (such as ketoconazole), terbinafine creams, or oral terbinafine for more resilient tinea pedis infections [Citation29].
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
In 2019, an outbreak of SARS-CoV-2, responsible for the COVID-19, resulted in a worldwide pandemic concerning to both civilian and military populations [Citation41]. COVID-19 is a multi-organ disease than can also affect the skin [Citation42]. The six main clinical patterns to the COVID-19 associated cutaneous manifestations include urticarial rash, maculopapular rash, papulovesicular exanthem, chilblain-like lesions, livedo reticularis/racemosa-like pattern, and vasculitic pattern [Citation43]. In 2021, 0.4% of the 131,694 medical encounters in US service members deployed to Southwest Asia, the Middle East, and Africa were for COVID-19, with skin diseases accounting for 5.9% of servicemen’s and 3.9% of servicewomen’s medical encounters [Citation44]. In an Italian study on the cutaneous manifestations of COVID-19 in 81 military patients and 15 civilians hospitalized in COVID-19 non-intensive care wards 3/16/2020–5/4/2020, 25 (31%) military patients and 9 civilians (60%) developed skin manifestations. The most common dermatologic diagnosis was xerosis in 11 (13.6%) military patients and 4 (26.7%) civilians. Other diagnoses included seborrheic dermatitis (3 cases in military group and 1 in civilian group), irritant CD (ICD) (3 cases in military group and 2 in civilian group), morbilliform rash (3 cases in military group and 1 in civilian group), petechial rash (2 cases in military group and 1 in civilian group), and urticaria (3 cases in military group and 0 in civilian group) [Citation42].
COVID-19 vaccines are effective in preventing systemic symptoms and cutaneous reactions, [Citation45,Citation46] but there was some resistance to vaccination within the military prior to mandates. A survey-based study 11/2020–1/2021 of 816 individuals associated with Wright-Patterson Air Force (AF) Base in the US (not limited to soldiers), reported that younger respondents (defined as 30 years or younger) were more likely to be vaccine hesitant than older (older than 30 years old) respondents (38% vs. 18% p < .001) [Citation47]. A case control study of 441,379 unvaccinated and fully vaccinated US military personnel tested for SARS-CoV-2 1/1/2021–9/24/2021, investigated two time periods before and after the new delta variant of SARS-CoV-2 emerged, the pre-delta period (1/1/2021–5/31/2021), and the delta period (6/19/2021–9/24/2021) respectively. Noteworthy, mandatory COVID-19 vaccination requirements for all military members went into effect on 8/24/2021. In the pre-delta period, 1% (n = 466/38,968) of positive SARS-CoV-2 tests and 14% (n = 34,243/251,288) of negative SARS-CoV-2 tests were reported in vaccinated military personnel and 99% (n = 38,501/38,968) of positive SARS-CoV-2 tests and 86% (n = 217,032/251,288) of negative SARS-CoV-2 tests were reported in unvaccinated military personnel. In the delta period, 38% (n = 10,041/26,087) of positive SARS-CoV-2 tests and 65% (n = 81,486/125,036) of negative SARS-CoV-2 tests were reported in vaccinated military personnel and 62% (n = 16,044/26,087) of positive SARS-CoV-2 tests and 35% (n = 43,537/125,036) of negative SARS-CoV-2 tests were reported in unvaccinated military personnel [Citation46].
Parasitic infections
Parasitic skin diseases may affect military soldiers who are often exposed to non-native environments and close living conditions. Parasitic infections accounted for 1% of the 2696 skin diagnoses in a military dermatology clinic in Iraq 1/15/2008–7/15/2008, and for 2.8% of the 81 skin diagnoses made in a military evacuation hospital in Saudi Arabia 2/3/1991–3/8/1991 [Citation19,Citation28]. In Iraq (1/15/2008-7/15/2008), these included scabies (n = 19), cutaneous larvae (n = 3), and cutaneous leishmaniasis (n = 1) [Citation28]. Military prevention of insect bites has commonly includes insecticide-treated clothing (such as permethrin, and DEET), and bed nets which are evidenced based [Citation48,Citation49].
Cutaneous leishmaniasis (CL)
Leishmaniasis is a sandfly borne parasitic infection that is transmissible between humans, which may affect the skin, mucosal membranes, and the reticuloendothelial system. The presentation can vary from asymptomatic, to self-limited CL, to visceral disease which is life threatening [Citation50]. The infection may not be immediately apparent and is often diagnosed after the soldier has returned home from deployment. In addition, CL presents similarly to other skin conditions making diagnosis challenging ( and ) [Citation51].
Leishmaniasis is endemic to many areas globally. On 1/8/2022, the World Health Organization (WHO) reported that 95% of CL cases occur in the Americas, Mediterranean basin, and Middle East and Central Asia [Citation52]. CL outbreaks were reported in military soldiers, often after returning from missions in deployed settings [Citation53–56]. Over 500 CL cases were diagnosed in military personnel returning from deployment in Afghanistan, Iraq and Kuwait 2002–2004 [Citation57]. A 2004 briefing of military operations in Iraq estimated that 10% of military persons deployed to the Persian Gulf area might have been infected with leishmaniasis [Citation8,Citation51].
Vector control program, and personal protective equipment, including long-sleeved uniforms treated with permethrin and mosquito repellents, may be used for the prevention of leishmaniasis in endemic areas [Citation58]. Yet, in a cross-sectional study of the use of personal protection in 300 Columbian soldiers who trained 10/2014–12/2014 in leishmaniasis-endemic areas, only 23% of soldiers reported complete use of personal protection measures (defined as complete military uniform treated with permethrin, rolled down long sleeves, cap and boots wearing, and application of mosquito repellant in all exposed body areas) [Citation59]. The only Food and Drug Administration (FDA) approved leishmaniasis medication in the US currently are Liposomal amphotericin B (IV infusion) for visceral leishmaniasis (VL), since 1997, and oral miltefosine (2, 50 mg oral capsules/day for 28 d) for CL, VL, and mucosal leishmaniasis (ML), since 2014 [Citation60]. Despite not being FDA approved for use in the US, sodium stibogluconate (SSG), with a standard daily dose of 20 mg/Kg (IV or IM) for 20 d for CL and 28 d for ML and VL, is a traditional treatment for simple CL lesions used since the 1940s in many parts of the world [Citation60]. A 2002 randomized double-blind study of SSG treatment for CL in 38 US military personnel infected with CL while abroad 8/1990–3/1991 and 9/1996–6/2001, there was no difference (p = .79) between treatment with SSG for 10 d vs. 20 d at 20 mg/kg, with cure rates of 100% (19/19) and 95% (n = 18/19), respectively, suggesting that 10 d of 20 mg/kg SSG may be sufficient treatment for CL [Citation61]. Some treatments are only effective against certain leishmaniasis infections and species, and individualized treatment regimens should include species identification [Citation60]. There is limited data supporting treatment regimens for leishmaniasis, meriting further research.
Scabies
Scabies is a highly contagious parasitic skin disease, which can cause significant morbidity due to severe itch () [Citation62]. Scabies was very common in the military setting in the eighteenth century and during a 1917 outbreak in the British military. However, incidence has since decreased, likely due to improved military hygiene, preventative health measures, and effective treatments [Citation63]. In a dermatology clinic in Iraq 1/15/2008–7/15/2008, there were only 19 cases of scabies from 2696 dermatologic diagnoses [Citation28]. In an East Timor deployment with 193 dermatologic diagnoses 9/27/1999–2/20/2000, there were no scabies infections [Citation5]. However, a scabies outbreak occurred in 2015 with 340 new cases of scabies in the French military following a national increase in scabies incidence across France [Citation62]. Prevention of scabies includes avoiding skin to skin contact or sharing items with an infected person, and prophylactic treatment upon exposure [Citation64]. Treatment includes permethrin 5% cream or malathion. An important aspect of treatment is washing all bedding and clothes, and prophylactic treatment of close contacts. Treatment failure is usually due to inadequate permethrin cream application, re-infestation, or permethrin resistance [Citation29]. Permethrin resistance is due to mutations in the voltage-sensitive sodium channel in neurons of scabies mites [Citation65]. In a Korean retrospective cohort study 1/2017–12/2020 of 138 scabies infestations with 38 (27.5%) treatment resistant infections, limited mobility (OR = 3.46, 95% CI) and topical steroid use prior to scabies diagnosis (OR = 3.65, 95% CI) were associated permethrin resistant infections [Citation66].
Other
Lymphatic filariasis (LF) is a parasitic infection transmitted by mosquitos that is manifested acutely by fever, lymphangitis, lymphadenopathy, and scrotal inflammation and chronically by lymphedema, elephantiasis and hydrocele. LF affects approximately 70 million globally. During World War 2 (WW2) many US soldiers were infected with LF, with the highest number of cases occurring in the central pacific. In Samoa, 70% of exposed troops contracted LF, and in Tonga there were 532 cases of LF in servicemen per year [Citation67,Citation68]. In a 2013–2014 survey and blood-slide based study of 16,467 Indian military personnel, 70 soldiers were positive for LF, with a decreasing positivity rate of 0.65% and 0.28% between 2013 and 2014 respectively, likely due to treatment given to positive cases throughout the study [Citation69]. Another study of 531 Chilean soldiers serving in Haiti, found that 10 tested positive for LF via IgG ELISA test, and concluded that the risk of contracting LF in endemic areas is low in those using appropriate preventative measures such as DEET based skin repellent, permethrin based repellent, weekly 500 mg chloroquine dose, and sleep protection [Citation70]. We did not find any studies that reported the tropical diseases onchocerciasis, buruli ulcer and yaws in military personnel.
Insect bites
Insect bites are common in soldiers, especially during operations and in the deployed setting ( and ). Multiple skin abrasions, sometimes accompanied by bullae, were detected in several French soldiers deployed to Gao, Mali, from 6/2014–10/2014. The bullae typically presented in the mornings and were due to toxigenic Cyaneolytta species blister beetles. The number of cases increased from 0–1 cases/month during May-July to 1–2 cases/month during August-October, the rainy season in Gao. Treatment included cleaning, debriding, and silver sulfadiazine dressings, followed by povidone iodine ointment in paraffin tulle gras dressings [Citation71]. Cutaneous myiasis, caused by bite and larvae of the Cordylobia anthropophaga () (African Thumb Fly), was described in a British soldier serving in Sierra Leone in 2003. He was treated with antiseptic washing and one tablet of the broad spectrum antibiotic co-amoxiclav (250 mg/125 mg) every eight hours for five days to prevent abscesses [Citation72]. In a battalion in 2007 Bangkok, 91% (n = 226/249) of Thai military soldiers experienced Paederus dermatitis, an ICD caused by Paederus beetles during an outbreak, with 34.1% of lesions presenting as bulla (n = 77/226), 33.6% as erythematous rash (n = 76/226), 20.8% as pustules (n = 47/226) and 17.3% as a ‘kissing lesion’ (n = 39/226). Treatment was supportive with oral antihistamines and topical steroids [Citation73]. Preventive measures against insect bites can include long sleeve clothing, bed nets, and the use of fluorescent lights [Citation71,Citation73].
Sexually transmitted infections (STIs)
STI’s were the 6th leading cause of military dermatologic consultations in a review of skin conditions in military operations [Citation9]. Of 2696 dermatologic diagnoses made in a dermatology clinic in Iraq 1/15/2008–7/15/2008, 5% (n = 136) were STI’s. Of the 136 STI diagnoses, condyloma accuminata that failed to resolve with initial treatment with topical imiquimod or 0.5 podofilox was the leading cause for a dermatological consultation. The soldiers were subsequently treated with liquid nitrogen and 25% podophyllin by dermatologists, with excellent response rate (2.3 visit mean clearance) [Citation28]. In a 2013–2021 report of the US Armed Forces, the most common STI’s in active service members were (in decreasing order of frequency) chlamydia, human papilloma virus (HPV), gonorrhea, genital herpes simplex virus (HSV), and syphilis [Citation75].
Chlamydia was the most common STI in the US in 2020, with a rate of 481.3 cases per 100,000 population [Citation76]. 2013–2021 chlamydia incidence rates among US Armed Forces service members were 197.6 per 10,000 p-yrs. Female vs. male service members had three times the annual incidence rates of chlamydia. 2013–2019, rates of chlamydia among both female and male US Armed Forces service members increased, with the highest rates reported in 2019 (546.0 per 10,000 p-yrs and 188.3 per 10,000 p-yrs, respectively), mainly due to increased incidence in service members under 25 years old [Citation75]. Gonorrhea was the second most common STI in the US in 2018, with a rate of 179.1 cases per 100,000 population [Citation77]. Gonorrhea incidence rates among US Armed Forces service members were 31.7 per 10,000 p-yrs 2013–2021. 2013–2018, rates of gonorrhea increased, and 2018–2021 rates decreased, in all groups except Black service members. In Black service members gonorrhea rates continued to increase 2013–2020 and then slightly decreased in 2021 [Citation75]. In 2018, syphilis rates in the US were 10.8 per 100,000 [Citation77]. Syphilis incidence rate among US Armed Forces service members was 5.0 per 10,000 p-yrs 2013–2021. Rates increased 2013 (3.2 per 10,000 p-yrs) to 2021 (6.1 per 10,000 p-yrs) in US Armed Forces service members, mostly due to an increase in cases among male service members [Citation75].
The National Health and Nutrition Examination Surveys (NHANES) reported a Vaccine-Preventable HPV (VP-HPV) subtypes seropositivity rate of 12.9% in the US among men ages 14–59 2003–2006 [Citation78]. In a study on the seroprevalence and sero-incidence of STI’s among US military personnel, the sero-incidence of VP-HPV 2000–2010 was 34% for the 199 male service members [Citation79,Citation80]. Seroprevalence of HSV in the US population among 14–49-year-olds 1999–2004 was 57.9% and 17.2% for HSV-1 and HSV-2 respectively [Citation81]. In a study of HSV seropositivity of 1094 military personnel ages 18–30 years old 1989–2005, sero-incidence rates at or before military enlistment were 40.7% and 7.5% for HSV-1 and HSV-2, respectively [Citation82]. In a study investigating of HSV seropositivity rates among 200 male and 200 female US service members 2006–2010, HSV-1 and HSV-2 seropositivity in female service members was 57.5% and 16.5% respectively, and 8% were positive for both (increase from rates of 39%, 4.0% and 1.5% respectively at enlistment). In male service members, seropositivity at the end of the 4-year study was 42.5%, 6%, and 3%, respectively (an increase from rates of 33.5%, 1.5% and 1.5% respectively at enlistment) [Citation79]. HSV infection rates are not higher in young adult military personnel than civilians, nevertheless, HSV and other STIs are a major cause of morbidity in military soldiers [Citation82].
The high prevalence of HPV and HSV in military soldiers highlights the importance of preventative measures in this population [Citation79]. HPV vaccination benefits both the solider and the healthcare system in decreasing burden and costs [Citation80]. However, HPV vaccination rates in active military members are low. Only 26.6% of eligible active servicewomen and 5.8% of servicemen initiated the HPV vaccination series in 2007–2017. Of those who initiated HPV vaccination, only 46.6% servicewomen and 35.1% completed the series [Citation83]. While the military offers coverage through military insurance, HPV vaccination is not mandatory for US military service [Citation84]. While there are several clinical trials for vaccines against genital herpes, currently there is no available HSV vaccine [Citation85], and also no vaccines for chlamydia, gonorrhea, and syphilis [Citation86]. Therefore, condom use with every sexual encounter decreases the risk of contracting STIs [Citation87]. Yet, in a 2014 DoD Health Related Behaviors Survey, 36.7% of active service members reported having sex without a condom with a new partner in the last year [Citation83]. The US Navy and Marine Corps promotes sexual responsibility and condom access, stocks condoms in minimum medical allowance lists, and provides free condoms in some settings [Citation88].
A new outbreak of monkeypox, an orthopoxvirus of the same family as smallpox, occurred in 5/2022. Close physical contact is a means of transmission, and in the most recent outbreak, was associated almost exclusively with sexual contact [Citation89,Citation90]. Monkeypox exanthems most commonly appear on the face, extremities, and groin and first presents as maculopapular eruptions that turn into vesicles that later crust () [Citation91]. Monkeypox cases have been described in military soldiers [Citation92]. Five unlinked cases of monkeypox in soldiers occurred during a monkeypox outbreak in British service personnel in 2022. [Citation93]. By 8/2022, 40 monkeypox cases were diagnosed in the US military. The Navy and Marine Corps Public Health Center has a system in place to track monkeypox cases across all military branches and determined that monkeypox risk in the military is low [Citation91]. There is no current approved treatment for monkeypox, but the antiviral medications tecovirimat, brincidofovir, and cidofovir used to treat smallpox are sometimes used. Intravenous vaccinia immune globulin, used to treat smallpox vaccine complications may also be authorized for use as treatment for monkeypox [Citation94]. The smallpox vaccine confers protection from monkeypox and smallpox infections and is recommended by the CDC for certain vulnerable population [Citation95].
Skin cancer
Skin cancer
There is increased prevalence of skin and keratinocyte cancers, compared to the general population, in military veterans who have served in active duty ( and ) [Citation97–100]. In the general population melanoma accounts for 1% of all skin cancers, and in an observational study of skin biopsies of the Walter Reed National Military Center, melanoma cases accounted for 5% (n = 54) of the 1084 cases of skin malignancy 8/2015–7/2016 [Citation99,Citation101]. Malignant neoplasms were the second most common post-evacuation diagnosis in 170 military personnel removed from deployment in Central and Southwest Asia 1/2003–12/2006 (n = 13) [Citation6]. During OIF, a US army operated dermatology clinic in Iraq reported that 8% of the 2696 total visits (n = 205) 1/15/2008–7/15/2008 were for skin cancer, including basal cell carcinoma (n = 70), squamous cell carcinoma (n = 68), mycosis fungoides (n = 1), and melanoma (n = 9), while 14% of visits (n = 357) were for benign skin tumors [Citation28,Citation102]. In an on-site dermatology clinic in Iraq, all benign lesions and most of the malignant lesions in Iraq were promptly treated [Citation102].
In their retrospective cohort study of 1545 White active duty military personnel diagnosed with melanoma 1990–2004, there was a lower risk of melanoma in White military personnel 20–44 years old (Incidence RR < 1.0), and increased risk in those older than 45 years old (Incidence RR > 1.0) compared to the general population (both p < .05) [Citation103]. A 2001–2015 surveillance study of 2233 melanoma diagnoses in the US military showed an exponential increase in malignant melanoma diagnoses relative to active service years, with a 12.8% increase with each additional year from 1st to 20th service years (R2 = 0.97) [Citation104]. The increased risk of melanoma is also military branch related, with the highest risk in US AF personnel [Citation103–108]. Airline pilots and cabin crew have approximately twice the risk of melanoma and other skin cancers as compared to the general population in a 2019 meta-analysis (of mostly studies from the 1970s and 1990s [Citation109]. Airline pilots are exposed to high average annual effective doses of radiation (3.07), and while modern airplane windows filter most ultraviolet (UV) B radiation, more than half of UVA radiation is unfiltered [Citation110]. A review of skin cancer in the US military published in 2021 emphasized that increased UV radiation exposure, inadequate utilization of sun-protection, and lack of education on risks for UV exposure were the leading factors contributing to the risk of skin cancer in military personnel [Citation97].
Sunburn
Sun exposure in military soldiers is often substantial due to spending long periods of time outdoors, which may also increase incidence and degree of photodermatitis [Citation111]. Prevention strategies include use of sunscreen with sun protective factor 30 or higher and hats, clothing that covers large areas of skin, and constructing shade [Citation112]. Two survey-based studies, one of 212 OIF and Operation New Dawn (OND) veterans 12/2013–5/2014, and the other of 356 AF personnel 3/2013–5/2013, reported that the majority (64% in both studies) of military personnel spent most of their days working in direct sun exposure, with only 13% and 11% respectively reporting regular use of sunscreen [Citation100,Citation105,Citation113]. Furthermore, in the 2013–2014 study of OIF and OND veterans, only 30% of participants reported having regular access to sunscreen [Citation113]. A 2016 US Army regulation for preventing environmental causalities states that it is the responsibility of brigade commanders to ensure soldiers have an adequate supply of sunscreen and that they use it daily [Citation114].
In a 2008–2013 surveillance study of the US AF that there were lower sunburn rates in the deployed vs. non-deployed settings, which may be influenced by less time for recreational activities and more frequent wearing of military uniforms [Citation115]. In a survey study of 212 veterans of OIF and OND 12/2013–5/2014, 63% had at least one sunburn during deployment which increased to 74% in those spending >6 h of the workday in the sun. Furthermore, 43% had 2+ sunburns, and 20% experienced blistering sunburns [Citation113]. In a 2002–2013 surveillance study of non-deployed US military personnel, 19,172 cases (crude incidence rate of 124.8 per 100,000) of sunburn were diagnosed, with higher incidence in females (female to male RR = 1.4), White (White to Black RR = 11.7), and younger service members (≤19 y.o to 45+ age groups RR = 10.4) [Citation112].
Acne
Acne is a common skin disease whose pathogenesis includes follicular hyperproliferation, excess sebum production, inflammation, and Propionibacterium acnes bacterial growth [Citation116]. Acne is especially common in the adolescent and young adult population, affecting 85% of 12–24 years olds. Since a large percentage (40.7% in 2018) of active-duty US military members are 25 years old or younger, acne is commonplace in the military ( and ) [Citation116–118]. Acne was diagnosed in 35.7% (n = 470) of 1321 male Korean soldiers ages of 19–24 4/2010–9/2010 and in 10.36% (n = 23) of 222 Norwegian soldiers (with no specific age group noted) 9/1996-5/1997 presenting with skin disease to the Oslo Military Clinic [Citation11,Citation23]. In a cross-sectional study of common skin diseases in the Korean military 4/2010–9/2010, acne prevalence was associated with increased time spent in the military (p = .022) [Citation23].
Acne and acne treatment can be especially challenging for military soldiers who are often required to maintain military grooming standards, are exposed to mechanical irritation, have reduced opportunity for personal hygiene, and have specific work conditions which may conflict with treatment [Citation119]. Many military soldiers returning from Iraq experienced moderate to severe cystic acne especially prominent in areas with chronic skin irritation from heavy military gear. In addition to the mechanical irritation experienced by wearing heavy garments, the hot weather conditions in Iraq and the decreased opportunity for hygiene likely contributed to acne development [Citation120]. Soldiers may have restricted treatment options due to potential side effects that may interfere with military duties. For example, military members in specialized military roles, such as pilots and submariners, may be disqualified from military duties when receiving treatment with isotretinoin, often making them undeployable [Citation117,Citation121]. Minocycline, which may cause central nervous system side effects, is considered a non-waiverable medication in the AF and thus is prohibited for treatment of aircrew service members [Citation122]. Doxycycline may not be advisable in environments with high UV indices due to potential photosensitivity [Citation121]. Preventative measures include skin hygiene, regular shampooing, avoidance of face touching, and reduced sun exposure, which may be difficult to maintain in a military settings [Citation123].
Military grooming practices- effects on the skin
Acne keloidalis nuchae (AKN)
To maintain uniformity in the military the US Army has grooming policies that emphasize neatly groomed hair. In male service members, hair must be tapered in appearance, meaning the hair must conform to the outline of the head [Citation124]. Likely associated with military grooming policies, diseases of hair and hair follicles were the second most prevalent skin condition in deployed US soldiers 2008–2015 accounting for 7.9%–15.16% of 429,837 dermatologic diagnoses [Citation10]. Male military hair grooming practices may contribute to the development or exacerbation of AKN [Citation119,Citation125]. AKN is more common in black males, with a prevalence of 0.5–13.6% in African-Americans and a male to female ratio of 20:1. Frequent haircuts may contribute to the pathogenesis of AKN [Citation119,Citation126]. Prevention of AKN progression may be difficult in military settings and includes avoiding mechanical irritation from clothes, and use of antimicrobial cleansers. Treatment involves a combination of steroids (topical, intralesional or systemic) and retinoids or antibiotics [Citation125].
Alopecia
In female service members with long hair, defined as extending below the collar, hair must be neatly fastened or pinned above the collar [Citation124]. Female military hair grooming practices may contribute to traction alopecia in female soldiers. Traction alopecia is associated with tight hairstyling. It is frequently seen in black and Hispanic women but can affect all races [Citation127]. Avoiding tight hair styles is imperative for preventing permanent hair loss [Citation128]. Military grooming practices may also exacerbate alopecia areata (AA). In a 2015 retrospective study of 1148 military conscripts and 2234 civilians, AA was significantly more common in the military population (5.4% vs. 1.7% p < .001) than civilians. In another retrospective study of 1658 dermatological consult of Chinese peacekeepers in Lebanon between 2007-2014, AA was one of the top five complaints and accounted for 5% of diagnoses [Citation129]. However, in a 2020 DoD effort to support inclusivity and diversity, the US Air Force and US Army authorized female servicemembers to wear longer braids and ponytails [Citation130].
Pseudofolliculitis Barbae (PFB)
As a general requirement, the US Army grooming policies emphasize a clean-shaven face when in uniform or on duty. Medical treatment may permit beard growth, though maximum authorized length must be specified [Citation124]. PFB is associated with facial hair shaving and qualifies for receipt of a military ‘shaving waiver’ () [Citation131,Citation132]. PFB predominantly affects 45% of African American service members [Citation10,Citation131,Citation133,Citation134], which might be due their higher prevalence of helical or spiral shaped hair [Citation132]. PFB rates decreased from 5.9% of dermatologic consults in the Vietnam War to 1.8% in OIF and less than 1% in more recent deployments, likely due to new treatment guidelines, shaving wavers, and military PFB clinics [Citation9,Citation131]. Treatments for PFB include grooming techniques, topical treatments (such as tretinoin and benzoyl peroxide/clindamycin combination), shaving waivers, and laser therapy [Citation131]. However, topical treatments can cause irritation, and permanent shaving wavers are often not permitted in the military (temporary shaving wavers are allowed). Laser therapy is associated with higher rates of complications in darker skinned individuals, including postinflammatory hyperpigmentation and scarring [Citation131]. Prevention is achieved by avoiding the trigger—shaving, however, for military soldiers who need to maintain a clean-shaven face, proper shaving techniques should be emphasized. Electric hair clippers are less likely to cause PFB. Other techniques include maintaining at least 1 mm of hair left behind after shaving, pre- and post- shaving care, and avoiding skin stretching or dry shaving [Citation123].
Managing skin conditions in soldiers
The US military follows strict medical eligibility criteria for enlisting soldiers, and disqualifies those with certain medical conditions, including chronic skin diseases, to protect the individual health of the applicant and ensure mission accomplishment in combat settings [Citation135]. However, soldiers with mild cases may receive a waiver [Citation136]. Chronic skin conditions can be especially difficult in the deployed setting. In a study of a United Nations peacekeeping mission in Darfur 3/2014–2/2015, 47.6% of the 542 soldiers with dermatologic disease were diagnosed before deployment [Citation18]. In their paper on military evacuations due to skin conditions 1/1/2003–12/31/2006, McGraw & Norton advised that pre-deployment military screening be performed for those with a history of chronic skin conditions, such that soldiers can be counseled on preventative measures and flares, or be recommended to avoid deployment [Citation6].
Diagnosis of atopic dermatitis (AD) after the 12th birthday is a disqualifying medical criterion for enlistment in the US military, though mild and well controlled cases often receive a waiver [Citation135,Citation137]. AD often flares in soldiers [Citation6], and correlates with stress levels experienced in the military. In a cross-sectional survey-based study of 1321 Korean soldiers 4/2010–9/2010, stress levels (measured with a 14-part questionnaire) was associated with both AD and seborrheic dermatitis (SD) (p = .003 in both) [Citation23]. Furthermore, environmental factors and lack of access to certain care measures, such as regular baths and moisturizers can exacerbate AD in soldiers [Citation136]. AD can causes ocular complications and poses a risk for secondary infections, which can be especially problematic in military settings [Citation138]. Treatment options of AD in soldiers include emollients, cleansers, and topical steroids and immunomodulators, and biologics. UV therapy can be used in non-deployed settings. Immunosuppressant use in soldiers is limited to short-term treatment due to their side effect profiles, need for laboratory monitoring, and immunosuppression [Citation137].
A diagnosis of psoriasis renders an applicant ineligible for military admission, however psoriasis can present after a soldier has already enlisted [Citation135]. In a study of dermatological diagnoses of US soldiers in the deployed setting 2008–2015, 0.8% of 429,837 deployed medical dermatological diagnoses and 4.0% of 452 teledermatology diagnoses were psoriasis [Citation10]. Psoriasis can cause discomfort and koebnerization when wearing body armor and make it difficult to wear military boots and helmets. Topical steroids, and steroid sparing agents may be used in military soldiers to treat psoriasis [Citation137]. Apremilast, is another treatment option, with no adverse effects on deployability [Citation137,Citation139]. Treatment with a biologic restricts a military soldier from deployment, but can be used in the non-deployed setting [Citation137].
Dermatitis
Dermatitis and eczematous conditions are common amongst military personnel who are exposed to weather extremes, psychological stress, and irritants and allergens ( and ) [Citation9,Citation18]. In a study of 170 US soldiers evacuated from military theater due to an unknown dermatologic condition 1/1/2003–12/31/2006, 20% (most common) received a dermatitis diagnosis post-evacuation [Citation6]. CD and other eczematous conditions accounted for 7.7% and 0.8%, respectively, of the 429,837 dermatologic diagnoses in deployed US soldiers 2008–2015 () [Citation10]. In studies of military missions to Lebanon (1/2018-5/2019), Iraq (1/2008–7/2008), and Sudan (3/2014–2/2015), dermatitis and eczema were the most common skin diagnoses accounting for 27.1% (n = 149/549), 17% (n = 462/2696), and 38.7% (n = 210/542) of cutaneous diagnoses, respectively [Citation17,Citation18,Citation28]. In contrast, in the tropical and humid environment of East Timor, 16% (n = 31/193) of dermatological conditions diagnosed 9/27/1999–2/20/2000 were dermatitis, mostly CD [Citation5].
In a 2007–2009 retrospective cohort study of 18,749 military conscripts in Singapore, CD affected in 0.4 conscripts/year and mostly affected the lower limbs and hands [Citation12]. In another retrospective study 1989–1999 of 77 occupational dermatoses in the Singapore army, ICD was 4.4 times more common than Allergic CD (ACD) [Citation140]. ICD in military soldiers is most frequently due to alcohols, oils, grease, disinfectants, soaps and cleaners, petroleum, solvents, and wet work [Citation140–143]. ACD occurs in military soldiers most commonly from exposure to military uniforms, camouflage, industrial fluids, shrapnel, and standard military vaccinations [Citation141]. Military soldiers with ACD had a significantly higher atopy rate and a shorter duration of dermatitis compared to civilians in a 2018 Israeli study of textile and shoe ACD [Citation144]. Untreated CD limits a soldier’s ability to participate in certain military duties and may lead discharge from the military. Therefore, proper diagnosis and management of both ICD and ACD is crucial [Citation141]. Management involves avoidance of the causative agent, topical steroids, antihistamines, topical immunomodulators (such as tacrolimus and pimecrolimus), and systemic corticosteroids for severe cases [Citation145–147]. The foundation of managing CD is prevention by educating the soldier about agents that may trigger CD [Citation148].
Onychocryptosis
Ingrown toenails, also known as ungus incarnatus and onychocryptosis, occur due to the nail plate piercing the nail fold causing an inflammatory reaction [Citation149]. Risk factors include repetitive toe trauma, nail injury, constricting footwear, and lack of grooming [Citation150]. In a 2014 retrospective prevalence study of 1148 male soldiers and 2234 male civilians evaluated at a dermatology clinic in Merzifon Military Hospital in Turkey, onychocryptosis prevalence was higher in the military group (3.3% VS. 0.3% p < .001) [Citation151]. Treatment of mild or moderate cases may be treated with open-toe footwear, managing underlying hyperhidrosis and onychomycosis if present, warm water soaks, gutter splints, cotton nail casts or metal braces. Recalcitrant and severe cases may be treated with phenol matricectomy, and is also more effective at preventing recurrence than non-surgical interventions [Citation150,Citation152].
Extreme weather conditions
Extreme weather conditions may affect soldiers who spend a larger portion of their day unsheltered in extreme cold or heat. Weather related injuries can have long-lasting effects on soldiers involving disfigurement and disability [Citation153]. However, most weather related skin injuries may be avoided with education, proper use of protective clothes and footwear [Citation111,Citation154].
In a US military surveillance study of 2524 cold injury cases 2009–2014, overall cold injury incidence rates were 36.2 per 100,000 p-yrs, with frostbite being the most common type, accounting for 1226 cold injury cases in all 4 military units (). Rates were higher in female service members with the most striking difference between incidence rates of male and female service members in the Army (85.4 vs 53.6 per 100,000 p-yrs, respectively). Cold injury incidence rates were higher among Black vs. White service members, especially in the Army (rates = 106.5 vs. 46.0 per 100,000 p-yrs, respectively) and Marine Corps (rate = 93.2 vs. 35.6 per 100,000 p-yrs, respectively) [Citation155]. Frostbite is a common cold injury in military soldiers and most commonly affects the digits, ears, nose, and facial skin. Often, the severity of frostbite injury is not evident until a day or two after warming the tissue [Citation153]. Other common cold weather injuries in military soldiers include immersion foot, pernio, Raynaud phenomenon, and cold urticaria [Citation156]. Weather injuries due to UV irradiation and heat can cause acute sunburn and might exacerbate preexisting skin conditions or result in photoreactions from medications [Citation111].
Occupational exposure
Occupational and warfare exposures may cause skin diseases in soldiers. For example, in the Iran-Iraq conflict, sulfur mustard (SM) was used for chemical warfare, with an Iranian military study of 40 soldiers exposed to SM 1983–1988, reporting hyperpigmentation (55%), xerosis (40%), cherry angiomas (37.5%), atrophy (27.5%), and hypopigmentation (25%) [Citation157]. There is evidence that organochlorine exposure during the Vietnam war is correlated with chloracne [Citation158]. ICD from direct skin contact to JP-5 jet fuel was reported in a 19-year-old US navy male sailor that was treated betamethasone valerate 0.1% ointment twice daily for two weeks followed by emollients three times daily for 4 weeks [Citation159]. Overall, 73,725 cases of plant dermatitis were reported in an 11-year surveillance study of US soldiers 1/1/2010–12/31/2020, with a crude rate of 5.3 per 1000 p-yrs, with higher rates among male service members (5.7 per 1000 p-yrs) and those in combat-related occupations (11.9 per 1000 p-yrs). White service members had an incidence rate of 7.5 per 1000 p-yrs compared 1.1 per 1000 p-yrs in Black service members. Case numbers were higher May to September (67% of all cases) and in Georgia (n = 12,874), California (n = 8764), North Carolina (n = 7707) and Virginia (n = 7125) [Citation160]. Prevention of occupational exposures in soldiers, who are vulnerable to different hazards than the general population, should include monitoring programs that use biomarkers to evaluate exposure [Citation161].
Future directions
Implementation of telemedicine can aid in diagnosing skin disease in military soldiers [Citation162,Citation163]. In a 2004–2012 retrospective study of the Department of Defense (DoD) teledermatology consultation program, teledermatology accounted for 40% of 10,817 teleconsultations, of which 84% were in military soldiers. Teledermatology requests were consulted in an average time of 5 h and 14 min, and prevented 46 evacuations [Citation164]. Use of mobile clinics as facilities for procedures may be a solution for managing dermatoses in soldiers, and were effective during the COVID-19 pandemic [Citation165].
Study limitations
This review is subject to certain limitations. As the focus of this review is on military populations, we were limited to including only military health information shared publicly. As most of the literature we found described the experiences of the US military, this review disproportionally includes studies focused on US soldiers. While several of the studies included in this review are from other countries, more studies exploring dermatological diseases affecting military populations throughout the world are needed. Studies on prevalence of lichen planus, hidradenitis suppurativa, and rosacea in military populations are outdated and limited.
Conclusions
Skin disease is amongst the most frequent reasons for soldiers and military personnel to seek medical care and can have a significant impact on soldiers’ wellbeing and ability to fulfill military duties. Military settings affect the presentation and spectrum of cutaneous disease in soldiers and the potential treatment and prevention options. Dermatitis and eczematous conditions were the most prevalent conditions in areas with hot and humid climates. Certain triggers of skin disease related to military standards, stress, and work-related exposures may be unavoidable in the military population. Some treatments used in the general population (such as isotretinoin, minocycline, biologic agents, immunosuppressant agents) may restrict military soldiers from fulfilling their military duties. Implications for military settings should be considered before initiation of treatment.
Authors contributions
Amit Singal participated in conception and design, methodology, draft preparation, and revising. Shari R. Lipner participated in conception and design, methodology, draft preparation, and revising. All authors have read and agreed to the published version of the manuscript. All authors agree to be accountable for all aspects of the work. All authors meet the four author criteria.
Acknowledgments
Amit Singal has served as a tank instructor in the Israel Defense Forces Armored Corps unit and acknowledges those who had served with her including the thousands of combat soldiers she had trained. Her personal experience helped with the conception of this project.
Disclosure statement
Ms. Singal has no conflicts of interest. Dr. Lipner has served as a consultant for Ortho-dermatologics, Hoth therapeutics, Moberg Pharmaceuticals, and BelleTorus Corporation.
Data availability statement
Data sharing is not applicable to this article as no new data were created or analyzed in this study.
Additional information
Funding
References
- Aiello AE, Lowy FD, Wright LN, et al. Meticillin-resistant Staphylococcus aureus among US prisoners and military personnel: review and recommendations for future studies. Lancet Infect Dis. 2006;6(6):1–21. doi: 10.1016/S1473-3099(06)70491-1.
- Morrison SM, Blaesing CR, Millar EV, et al. Evaluation of methicillin-resistant Staphylococcus aureus skin and soft-tissue infection prevention strategies at a military training center. Infect Control Hosp Epidemiol. 2013;34(8):841–843. doi: 10.1086/671278.
- Stahlman S, Williams VF, Oh GT, et al. Skin and soft tissue infections, active component, U.S. Armed Forces, 2013-2016. Msmr. 2017;24(7):2–11.
- GtFoSa L. 2021 Military Active-Duty Personnel, Civilians by State. 2022. https://www.governing.com/now/2021-military-active-duty-personnel-civilians-by-state.
- Lim DS. Dermatology in the military: an East timor study. Int J Dermatol. 2005;44(4):304–311. doi: 10.1111/j.1365-4632.2004.01670.x.
- McGraw TA, Norton SA. Military aeromedical evacuations from central and southwest Asia for ill-defined dermatologic diseases. Arch Dermatol. 2009;145(2):165–170. doi: 10.1001/archdermatol.2008.554.
- Henning JS, Wohltmann W, Hivnor C. Teledermatology from a combat zone. Arch Dermatol. 2010;146(6):676–677. doi: 10.1001/archdermatol.2010.110.
- Arnold JG, Michener MD. Evaluation of dermatologic conditions by primary care providers in deployed military settings. Mil Med. 2008;173(9):882–888. doi: 10.7205/milmed.173.9.882.
- Gelman AB, Norton SA, Valdes-Rodriguez R, et al. A review of skin conditions in modern warfare and peacekeeping operations. Mil Med. 2015;180(1):32–37. doi: 10.7205/MILMED-D-14-00240.
- Gregory JF, Taylor EA, Liu YE, et al. The burden of skin disease on deployed servicemembers. Mil Med. 2019;184(11-12):889–893. doi: 10.1093/milmed/usz110.
- Selvaag E. Skin disease in military personnel. Military Med. 2000;165(3):193–194. doi: 10.1093/milmed/165.3.193.
- Gan WH, Low R, Koh D. Dermatological conditions in military conscripts. Occup Med. 2013;63(6):435–438. doi: 10.1093/occmed/kqt077.
- Schissel DJ, Wilde JL. Operational dermatology. Mil Med. 2004;169(6):444–447. doi: 10.7205/milmed.169.6.444.
- Pillsbury DM, Livingood CS. Experiences in military dermatology: their interpretation in plans for improved general medical care. Arch Derm Syphilol. 1947;55(4):441–462. doi: 10.1001/archderm.1947.01520040010002.
- Mac KR. On military dermatology. Br Med Bull. 1945;3(7–8):158–161.
- Pendlebury GA, Oro P, Ludlow K, et al. Relevant dermatoses among U.S. military service members: an operational review of management strategies and telemedicine utilization. Cureus. 2023;15(1):e33274. doi: 10.7759/cureus.33274.
- Wang X, Yang H, Wang Y, et al. Analysis of cases managed by dermatological service in the Chinese peacekeeping level 1+ medical treatment facility in Lebanon, 2018–2019. BMJ Mil Health. 2021;167(6):429–432. doi: 10.1136/jramc-2019-001315.
- Anwar MI, Malik NA, Raja A, et al. Skin diseases among peacekeepers at United Nations and African Mission in Darfur. J Pakistan Assoc Dermatologists. 2016;26(1):53–57.
- Pehr K, Kornfeld BW. Dermatology in a war zone: a Persian Gulf experience. Int J Dermatol. 1992;31(7):494–497. doi: 10.1111/j.1365-4362.1992.tb02698.x.
- Driver JM, Simpson R, Wall C, et al. Dermatology on operation HERRICK. J R Army Med Corps. 2012;158(3):232–237; discussion 237. doi: 10.1136/jramc-158-03-18.
- Allen AM. Internal Medicine in Vietnam, 1965-72. [department of defense, department of the army]. Army Medical Department, Center of Military History. Washington, D.C; 1977.
- Sasmaz S, Celik M. Skin diseases in Turkish soldiers. Dermatologica Sinica. 2011;29(2):44–46. doi: 10.1016/j.dsi.2011.05.001.
- Bae JM, Ha B, Lee H, et al. Prevalence of common skin diseases and their associated factors among military personnel in Korea: a cross-sectional study. J Korean Med Sci. 2012;27(10):1248–1254. doi: 10.3346/jkms.2012.27.10.1248.
- Fisher A, Webber BJ, Pawlak MT, et al. Epidemiology, microbiology, and antibiotic susceptibility patterns of skin and soft tissue infections, Joint Base San Antonio-Lackland, Texas, 2012–2014. MSMR. 2015;22(7):2–6.
- Millar EV, Rice GK, Elassal EM, et al. Genomic characterization of USA300 Methicillin-Resistant Staphylococcus aureus (MRSA) to evaluate intraclass transmission and recurrence of skin and soft tissue infection (SSTI) among High-Risk military trainees. Clin Infect Dis. 2017;65(3):461–468. doi: 10.1093/cid/cix327.
- Stahlman S, Williams VF, Oh GT, et al. Skin and soft tissue infections, active component, U.S. Armed Forces, January 2016-September 2020. MSMR. 2021;28(4):27–38.
- May L, Porter C, Tribble D, et al. Self-reported incidence of skin and soft tissue infections among deployed US military. Travel Med Infect Dis. 2011;9(4):213–220. doi: 10.1016/j.tmaid.2011.06.001.
- Henning JS, Firoz BF. Combat dermatology: the prevalence of skin disease in a deployed dermatology clinic in Iraq. J Drugs Dermatol. 2010;9(3):210–214.
- Lamb L, Morgan M. Skin and soft tissue infections in the military. J R Army Med Corps. 2013;159(3):215–223. doi: 10.1136/jramc-2013-000134.
- Djeridane A, Djeridane Y, Ammar-Khodja A. A clinicomycological study of fungal foot infections among algerian military personnel. Clin Exp Dermatol. 2007;32(1):60–63. doi: 10.1111/j.1365-2230.2006.02265.x.
- Williams VF, Stahlman S, McNellis MG. Brief report: Tinea pedis, active component, U.S. Armed Forces, 2000–2016. MSMR. 2017;24(5):19–21.
- Lipner SR, Scher RK. Onychomycosis: clinical overview and diagnosis. J Am Acad Dermatol. 2019;80(4):835–851. doi: 10.1016/j.jaad.2018.03.062.
- Bell-Syer SE, Khan SM, Torgerson DJ. Oral treatments for fungal infections of the skin of the foot. Cochrane Database Syst Rev. 2012;10(10):CD003584.
- Cohen AD, Wolak A, Alkan M, et al. Prevalence and risk factors for tinea pedis in Israeli soldiers. Int J Dermatol. 2005;44(12):1002–1005. doi: 10.1111/j.1365-4632.2005.02281.x.
- Kintsurashvili N, Kvlividze O, Galdava G. Prevalence and risk factors of tinea pedis in Georgian defense forces. BMJ Mil Health. 2021;167(6):433–436. doi: 10.1136/bmjmilitary-2019-001397.
- Noguchi H, Hiruma M, Kawada A, et al. Tinea pedis in members of the Japanese self-defence forces: relationships of its prevalence and its severity with length of military service and width of interdigital spaces. Mycoses. 1995;38(11–12):495–499. doi: 10.1111/j.1439-0507.1995.tb00027.x.
- Lipner SR, Scher RK. Onychomycosis: treatment and prevention of recurrence. J Am Acad Dermatol. 2019;80(4):853–867. doi: 10.1016/j.jaad.2018.05.1260.
- Kang R, Lipner S. Consumer preferences of antifungal products for treatment and prevention of tinea pedis. J Dermatolog Treat. 2019;30(8):745–749. doi: 10.1080/09546634.2019.1572862.
- Lipner SR, Scher RK. Management of onychomycosis and co-existing tinea pedis. J Drugs Dermatol. 2015;14(5):492–494.
- Oumeish OY, Parish LC. Marching in the army: common cutaneous disorders of the feet. Clin Dermatol. 2002;20(4):445–451. doi: 10.1016/s0738-081x(02)00247-x.
- Riley P, Ben-Nun M, Turtle J, et al. COVID-19: on the disparity in outcomes between military and civilian populations. Mil Med. 2023;188(1–2):311–315. doi: 10.1093/milmed/usab404.
- Di Nunno D, Laghi A, Troiani G, et al. Cutaneous manifestations in an Italian military COVID hub. G Ital Dermatol Venereol. 2020;155(5):632–635. doi: 10.23736/S0392-0488.20.06735-8.
- Genovese G, Moltrasio C, Berti E, et al. Skin manifestations associated with COVID-19: current knowledge and future perspectives. Dermatology. 2021;237(1):1–12. doi: 10.1159/000512932.
- Armed Forces Health Surveillance Division. Morbidity burdens attributable to various illnesses and injuries, deployed active and reserve component service members, U.S. Armed Forces, 2021. MSMR. 2022;29(6):34–39.
- Mohamed K, Rzymski P, Islam MS, et al. COVID-19 vaccinations: the unknowns, challenges, and hopes. J Med Virol. 2022;94(4):1336–1349. doi: 10.1002/jmv.27487.
- Eick-Cost AA, Ying S, Wells N. Effectiveness of mRNA-1273, BNT162b2, and JNJ-78436735 COVID-19 vaccines among US military personnel before and during the predominance of the Delta variant. JAMA Netw Open. 2022;5(4):e228071. doi: 10.1001/jamanetworkopen.2022.8071.
- Theis SR, Li PC, Kelly D, et al. Perceptions and concerns regarding COVID-19 vaccination in a military base population. Mil Med. 2022;187(11–12):e1255–e1260.
- Banks SD, Murray N, Wilder-Smith A, et al. Insecticide-treated clothes for the control of vector-borne diseases: a review on effectiveness and safety. Med Vet Entomol. 2014;28(Suppl 1):14–25. doi: 10.1111/mve.12068.
- Kitchen LW, Lawrence KL, Coleman RE. The role of the United States military in the development of vector control products, including insect repellents, insecticides, and bed nets. J Vector Ecol. 2009;34(1):50–61. doi: 10.1111/j.1948-7134.2009.00007.x.
- Weina PJ, Neafie RC, Wortmann G, et al. Old world leishmaniasis: an emerging infection among deployed US military and civilian workers. Clin Infect Dis. 2004;39(11):1674–1680. doi: 10.1086/425747.
- Pehoushek JF, Quinn DM, Crum WP. Cutaneous leishmaniasis in soldiers returning from deployment to Iraq. J Am Acad Dermatol. 2004;51(5 Suppl):S197–S200. doi: 10.1016/j.jaad.2004.06.018.
- World Health Organization. Leishmaniasis. 2022 [cited 2022 Jan 8]. https://www.who.int/news-room/fact-sheets/detail/leishmaniasis#:∼:text=It%20remains%20one%20of%20the,South%20Sudan%2C%20Sudan%20and%20Yemen.
- Henry K, Mayet A, Hernandez M, et al. Outbreak of cutaneous leishmaniasis among military personnel in French Guiana, 2020: clinical, phylogenetic, individual and environmental aspects. PLOS Negl Trop Dis. 2021;15(11):e0009938. doi: 10.1371/journal.pntd.0009938.
- Oré M, Sáenz E, Cabrera R, et al. Outbreak of cutaneous leishmaniasis in Peruvian military personnel undertaking training activities in the amazon basin, 2010. Am J Trop Med Hyg. 2015;93(2):340–346. doi: 10.4269/ajtmh.15-0107.
- Bailey MS, Caddy AJ, McKinnon KA, et al. Outbreak of zoonotic cutaneous leishmaniasis with local dissemination in Balkh, Afghanistan. J R Army Med Corps. 2012;158(3):225–228. doi: 10.1136/jramc-158-03-16.
- Bailey MS. Tropical skin diseases in British military personnel. J R Army Med Corps. 2013;159(3):224–228. doi: 10.1136/jramc-2013-000124.
- Update: cutaneous leishmaniasis in U.S. military personnel–Southwest/Central Asia, 2002-2004. MMWR Morb Mortal Wkly Rep. 2004;53(12):264–265.
- Coleman RE, Burkett DA, Putnam JL, et al. Impact of phlebotomine sand flies on U.S. Military operations at Tallil Air Base, Iraq: 1. background, military situation, and development of a “Leishmaniasis Control Program”. J Med Entomol. 2006;43(4):647–662. doi: 10.1093/jmedent/43.4.647.
- González AM, Solís-Soto MT, Radon K. Leishmaniasis: who uses personal protection among military personnel in Colombia? Ann Glob Health. 2017;83(3–4):519–523. doi: 10.1016/j.aogh.2017.10.015.
- CDC. Parasites – Leishmaniasis, Resources for Health Professionals. 2023. https://www.cdc.gov/parasites/leishmaniasis/health_professionals/index.html#:∼:text=Conventional%20amphotericin%20B%20deoxycholate%20traditionally,tolerated%20than%20conventional%20amphotericin%20B.
- Wortmann G, Miller RS, Oster C, et al. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel. Clin Infect Dis. 2002;35(3):261–267. doi: 10.1086/341406.
- Brossier C, Morand JJ, Breton A, et al. Scabies among the French armed forces in 2015. J Infect. 2016;73(3):297–300. doi: 10.1016/j.jinf.2016.06.009.
- Croft A, Smith H, Creamer I. A pseudo-outbreak of skin disease in British troops. J R Soc Med. 1996;89(10):552–556. doi: 10.1177/014107689608901004.
- Centers for Disease Control and Prevention. Prevention & Control. Parasites-Scabies. 2018. https://www.cdc.gov/parasites/scabies/prevent.html#:∼:text=Scabies%20is%20prevented%20by%20avoiding,skin%2Dto%2Dskin%20contact.
- Pasay C, Arlian L, Morgan M, et al. High-resolution melt analysis for the detection of a mutation associated with permethrin resistance in a population of scabies mites. Med Vet Entomol. 2008;22(1):82–88. doi: 10.1111/j.1365-2915.2008.00716.x.
- Lee SK, Kim JH, Kim MS, et al. Risk factors for scabies treatment resistance: a retrospective cohort study. J Eur Acad Dermatol Venereol. 2022;36(1):126–132. doi: 10.1111/jdv.17713.
- Melrose WD, Leggat PA. Acute lymphatic filariasis infection in United States armed forces personnel deployed to the pacific area of operations during world war II provides important lessons for today. Trop Med Infect Dis. 2020;5(2):63.
- Beaver PC. Filariasis without microfilaremia. Am J Trop Med Hyg. 1970;19(2):181–189. doi: 10.4269/ajtmh.1970.19.181.
- Kushwaha AS, Verma KC, Cariappa MP. Filaria surveys in the armed forces: need for a revisit. Med J Armed Forces India. 2017;73(4):332–337. doi: 10.1016/j.mjafi.2016.09.012.
- Weitzel T, Rosas R, Fica A, et al. Is there a risk of filarial infection during long-term missions in Haiti? Travel Med Infect Dis. 2016;14(2):137–142. doi: 10.1016/j.tmaid.2015.12.001.
- Aoun O, François M, Demoncheaux JP, et al. Morning blisters: cantharidin-related meloidae burns. J Travel Med. 2018;25(1):tay045.
- Parkhouse D. Cutaneous myiasis due to the tumbu fly during operation keeling. J R Army Med Corps. 2004;150(1):24–26. doi: 10.1136/jramc-150-01-05.
- Suwannahitatorn P, Jatapai A, Rangsin R. An outbreak of paederus dermatitis in Thai military personnel. J Med Assoc Thai. 2014;97(2):S96–S100.
- Deng Y, Liu F, Chen X, et al. The first imported cutaneous myiasis due to cordylobia anthropophaga in China. Int J Dermatol. 2013;52(1):120–122. doi: 10.1111/j.1365-4632.2010.04823.x.
- Armed Forces Health Surveillance Division. Update: sexually transmitted infections, active component, U.S. Armed Forces, 2013-2021. MSMR. 2022;29(5):2–11.
- CDC. Sexually Transmitted Disease Surveillance 2020. National Overview of STDs, 2020. 2022 [cited 2023 Jan 4]. https://www.cdc.gov/std/statistics/2020/overview.htm#. Chlamydia.
- CDC. Sexually transmitted disease surveillance 2018. 2018 [cited 2023 Jan 4]. https://www.cdc.gov/std/stats18/STDSurveillance2018-full-report.pdf.
- Introcaso CE, Dunne EF, Hariri S, et al. Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the U.S.A., National Health and Nutrition examination surveys, 2003–2006. Sex Transm Infect. 2014;90(6):505–508. doi: 10.1136/sextrans-2013-051490.
- Masel J, Deiss RG, Wang X, et al. Seroprevalence and seroincidence of herpes simplex virus (2006–2010), syphilis (2006–2010), and vaccine-preventable human papillomavirus subtypes (2000–2010) among US military personnel. Sex Transm Dis. 2015;42(5):253–258. Maydoi: 10.1097/OLQ.0000000000000277.
- Agan BK, Macalino GE, Nsouli-Maktabi H, et al. Human papillomavirus seroprevalence among men entering military service and seroincidence after ten years of service. Msmr. 2013;20(2):21–24.
- Bradley H, Markowitz LE, Gibson T, et al. Seroprevalence of herpes simplex virus types 1 and 2–United States, 1999–2010. J Infect Dis. 2014;209(3):325–333. doi: 10.1093/infdis/jit458.
- Page WF, Chubb M, Feng X, et al. National estimates of seroincidence and seroprevalence for herpes simplex virus type 1 and type 2 among US military adults aged 18–29 years. Sex Transm Dis. 2012;39(4):241–250. doi: 10.1097/OLQ.0b013e3182401a17.
- Clark LL, Stahlman S, Taubman SB. Human papillomavirus vaccine initiation, coverage, and completion rates among U.S. active component service members, 2007–2017. MSMR. 2018;25(9):9–14.
- Penick E, Grabert BK, Stockton E, et al. Feasibility and sustainability of a nurse-led intervention to integrate HPV vaccination into medical processing for active-duty soldiers. Hum Vaccin Immunother. 2022;18(7):2153536. doi: 10.1080/21645515.2022.2153536.
- CDC. Genital herpes treatment and care. 2021 [cited 2023 Jan 4]. https://www.cdc.gov/std/herpes/treatment.htm#:∼:text=Though%20several%20clinical%20trials%20have,not%20infected%20with%20HSV%2D1.
- WHO. Sexually transmitted infections (STIs). 2022 [cited 2023]. https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis).
- CDC. Genital herpes – CDC basic fact sheet. 2022 [cited 2023 Jan 4]. https://www.cdc.gov/std/herpes/stdfact-herpes.htm#:∼:text=How%20can%20I%20prevent%20genital,who%20does%20not%20have%20herpes.
- Center NaMCPH. Targeted condom access for disease and pregnancy prevention. 2018 [cited 2023 Jan 6]. https://www.med.navy.mil/Portals/62/Documents/NMFA/NMCPHC/root/Health%20Promotion%20and%20Wellness/Condoms/targeted-condom-access-for-disease-and-pregnancy-prevention.pdf?ver=ed4GKulomCezmUkqeAazyg%3d%3d.
- WHO. Monkeypox. 2022 [cited 2023 Jan 4]. https://www.who.int/news-room/fact-sheets/detail/monkeypox.
- CDC. Safer sex, social gatherings, and Mpox. 2023. https://www.cdc.gov/poxvirus/monkeypox/prevention/sexual-health.html.
- Pendlebury GA, Roman J, Shrivastava V, et al. A call to action: evidence for the military integration of teledermoscopy in a pandemic era. Dermatopathology. 2022;9(4):327–342. doi: 10.3390/dermatopathology9040039.
- Pembi E, Awang S, Salaudeen SO, et al. First confirmed case of monkeypox in Adamawa state, Nigeria: a clinico-epidemiological case report. Pan Afr Med J. 2022;42:38. doi: 10.11604/pamj.2022.42.38.34715.
- Woolley SD, Dermont M, Adam M, et al. The 2022 monkeypox outbreak: a UK military perspective. Travel Med Infect Dis. 2023;52:102540. doi: 10.1016/j.tmaid.2022.102540.
- Disease NIoAaI. Mpox (Formerly Monkeypox) treatment: diseases & conditions. 2022. https://www.niaid.nih.gov/diseases-conditions/mpox-treatment#:∼:text=Currently%2C%20there%20is%20no%20specific,may%20help%20patients%20with%20mpox.
- CDC. Mpox. Poxvirus. 2023. https://www.cdc.gov/poxvirus/monkeypox/vaccines/index.html.
- Vallée A, Farfour E, Zucman D. Monkeypox virus: a novel sexually transmitted disease? A case report from France. Travel Med Infect Dis. 2022;49:102394. doi: 10.1016/j.tmaid.2022.102394.
- Gall R, Bongiorno M, Handfield K. Skin cancer in the US military. Cutis. 2021;107(1):29–33. doi: 10.12788/cutis.0153.
- Durmishi A, Fida M, Hoxha S, et al. Are military personnel at a more risk for skin cancers? Dermatol Ther. 2020;33(6):e14340.
- Yong J, Raiciulescu S, Coffman M, et al. Skin malignancy in the military: a number needed to biopsy analysis. Mil Med. 2022;187(5-6):e624–e629. doi: 10.1093/milmed/usab039.
- Parker G, Williams B, Driggers P. Sun exposure knowledge and practices survey of maintenance squadrons at Travis AFB. Mil Med. 2015;180(1):26–31. doi: 10.7205/MILMED-D-14-00091.
- American Cancer Society. Key statistics for melanoma skin cancer. Facts & figures. 2022. https://www.cancer.org/cancer/melanoma-skin-cancer/about/key-statistics.html.
- Henning JS, Firoz BF. Contribution of dermatologic surgery in war. Dermatol Surg. 2010;36(1):1–7. doi: 10.1111/j.1524-4725.2009.01377.x.
- Zhou J, Enewold L, Zahm SH, et al. Melanoma incidence rates among whites in the U.S. Military. Cancer Epidemiol Biomarkers Prev. 2011;20(2):318–323. doi: 10.1158/1055-9965.EPI-10-0869.
- Brundage JF, Williams VF, Stahlman S, et al. Incidence rates of malignant melanoma in relation to years of military service, overall and in selected military occupational groups, active component. U.S. Armed Forces, 2001-2015. MSMR. 2017;24(2):8–14.
- Riemenschneider K, Liu J, Powers JG. Skin cancer in the military: a systematic review of melanoma and nonmelanoma skin cancer incidence, prevention, and screening among active duty and veteran personnel. J Am Acad Dermatol. 2018;78(6):1185–1192. doi: 10.1016/j.jaad.2017.11.062.
- Lea CS, Efird JT, Toland AE, et al. Melanoma incidence rates in active duty military personnel compared with a population-based registry in the United States, 2000–2007. Mil Med. 2014;179(3):247–253. doi: 10.7205/MILMED-D-13-00356.
- Lee T, Williams VF, Clark LL. Incident diagnoses of cancers in the active component and cancer-related deaths in the active and reserve components, U.S. Armed Forces, 2005–2014. MSMR. 2016;23(7):23–31.
- Wilkison BD, Wong EB. Skin cancer in military pilots: a special population with special risk factors. Cutis. 2017;100(4):218–220.
- Miura K, Olsen CM, Rea S, et al. Do airline pilots and cabin crew have raised risks of melanoma and other skin cancers? Systematic review and meta‐analysis. Br J Dermatol. 2019;181(1):55–64. doi: 10.1111/bjd.17586.
- Yong SS, Han WH, Faheem NAA, et al. Predictive factors of sun protection behaviour among global airline pilots. Photodermatol Photoimmunol Photomed. 2022;38(6):541–547. doi: 10.1111/phpp.12787.
- Gatt P, Pace J. Environmental skin diseases in military personnel. Clin Dermatol. 2002;20(4):420–424. doi: 10.1016/s0738-081x(02)00243-2.
- Armed Forces Health Surveillance Center. Sunburn among active component service members, U.S. Armed Forces, 2002-2013. MSMR. 2014;21(7):2–6.
- Powers JG, Patel NA, Powers EM, et al. Skin cancer risk factors and preventative behaviors among United States military veterans deployed to Iraq and Afghanistan. J Invest Dermatol. 2015;135(11):2871–2873. doi: 10.1038/jid.2015.238.
- Army Dot. Prevention of heat and cold casualties. *TRADOC Regulation 350-29. 2016. https://adminpubs.tradoc.army.mil/regulations/TR350-29.pdf
- Brief report: sunburn diagnoses while deployed in Southwest/Central Asia, active component, U.S. Armed Forces, 2008-2013. MSMR. 2014;21(7):7–9.
- Duquia RP, de Almeida HL, Breunig JA, et al. Most common patterns of acne in male adolescents: a population-based study. Int J Dermatol. 2013;52(5):550–553. Maydoi: 10.1111/j.1365-4632.2011.05333.x.
- Park AM, Brahe C. Oral isotretinoin for acne in the US military: how accelerated courses and teledermatology can minimize the duty-limiting impacts of treatment. Cutis. 2022;109(2):75–78. doi: 10.12788/cutis.0452.
- US Department of Defense. 2018 Demographics report: profile of the military community. 2018. https://download.militaryonesource.mil/12038/MOS/Reports/2018-demographics-report.pdf.
- Brahe C, Peters K, Meunier N. Acne keloidalis nuchae in the armed forces. Cutis. 2020;105(5):223–226.
- Perry A, Trafeli J, Schulze R. Iraqne, acne in the modern soldier. Mil Med. 2008;173(8):ix–xi.
- Brahe C, Peters K. Fighting acne for the fighting forces. Cutis. 2020;106(1):18–20;22. doi: 10.12788/cutis.0057.
- Force USA. Official air force aerospace medicine approved medications. 2017. https://www.315aw.afrc.af.mil/Portals/13/Users/096/96/96/Aircrew%20Medication%20List%20June%202017.pdf?ver=2017-07-13-121648-710.
- Dermatology AAo. ACNE: tips for managing. 2022. https://www.aad.org/public/diseases/acne/skin-care/tips.
- Army UDot. Wear and appearance of army uniforms and insignia. 2021 [cited 2022 Sept 23]. https://armypubs.army.mil/epubs/DR_pubs/DR_a/ARN30302-AR_670-1-000-WEB-1.pdf.
- Maranda EL, Simmons BJ, Nguyen AH, et al. Treatment of acne keloidalis nuchae: a systematic review of the literature. Dermatol Ther. 2016;6(3):363–378. doi: 10.1007/s13555-016-0134-5.
- Ogunbiyi A. Acne keloidalis nuchae: prevalence, impact, and management challenges. Clin Cosmet Investig Dermatol. 2016;9:483–489. doi: 10.2147/CCID.S99225.
- Weiss AN, Arballo OM, Miletta NR, et al. Military grooming standards and their impact on skin diseases of the head and neck. Cutis. 2018;102(5):328.
- Association AAoD. Hairstyles that pull can lead to hair loss. 2023. https://www.aad.org/public/diseases/hair-loss/causes/hairstyles.
- Zhou Z, Liu T, Zhang Z. Skin disease in united nations peacekeepers in Lebanon. J R Army Med Corps. 2017;163(1):27–30. doi: 10.1136/jramc-2015-000601.
- May Franklin JM, Wohltmann WE, Wong EB. From buns to braids and ponytails: entering a new era of female military hair-grooming standards. Cutis. 2021;108(1):31–35. doi: 10.12788/cutis.0296.
- Tshudy MT, Cho S. Pseudofolliculitis barbae in the U.S. Military, a review. Mil Med. 2021;186(1-2):e52–e57. doi: 10.1093/milmed/usaa243.
- Garcia-Zuazaga J. Pseudofolliculitis barbae: review and update on new treatment modalities. Mil Med. 2003;168(7):561–564. doi: 10.1093/milmed/168.7.561.
- Perry PK, Cook-Bolden FE, Rahman Z, et al. Defining pseudofolliculitis barbae in 2001: a review of the literature and current trends. J Am Acad Dermatol. 2002;46(2 Suppl):S113–S9. Febdoi: 10.1067/mjd.2002.120789.
- Coquilla BH, Lewis CW. Management of pseudofolliculitis barbae. Mil Med. 1995;160(5):263–269. doi: 10.1093/milmed/160.5.263.
- DOD. Medical standards for appointment, enlistment, or induction. (DoD Instructions 6130.03, Volume 1). 2018. https://www.esd.whs.mil/Portals/54/Documents/DD/issuances/dodi/613003_v1p.PDF?ver=9NsVi30gsHBBsRhMLcyVVQ%3D%3D.
- Riegleman KL, Farnsworth GS, Wong EB. Atopic dermatitis in the US military. Cutis. 2019;104(3):144–147.
- Burke KR, Larrymore DC, Cho S. Treatment consideration for US military members with skin disease. Cutis. 2019;103(6):329–332.
- Jeter J, Bowen C. Atopic dermatitis and implications for military service. Mil Med. 2019;184(5-6):e177–e82. doi: 10.1093/milmed/usy427.
- Hathaway NE, Lyford WH. Apremilast uses and relevance to the military. Cutis. 2021;107(4):216–220. doi: 10.12788/cutis.0231.
- Goon AT, Goh CL. Occupational skin diseases in national servicemen and military personnel in Singapore, 1989–1999. Contact Dermatitis. 2001;44(2):89–90. doi: 10.1034/j.1600-0536.2001.440206.x.
- Dever TT, Walters M, Jacob S. Contact dermatitis in military personnel. Dermatitis. 2011;22(6):313–319.
- Beltrani VS, Beltrani VP. Contact dermatitis. Ann Allergy Asthma Immunol. 1997;78(2):160–175. doi: 10.1016/S1081-1206(10)63383-2.
- Zeller S, Warshaw E. Allergic contact dermatitis. Minn Med. 2004;87(3):38–42.
- Slodownik D, Reiss A, Mashiach Y, et al. Textile and shoe allergic contact dermatitis in military personnel. Dermatitis. 2018;29(4):196–199. Jul/Augdoi: 10.1097/DER.0000000000000390.
- Brar KK. A review of contact dermatitis. Ann Allergy Asthma Immunol. 2021;126(1):32–39. doi: 10.1016/j.anai.2020.10.003.
- Li Y, Li L. Contact dermatitis: classifications and management. Clin Rev Allergy Immunol. 2021;61(3):245–281. doi: 10.1007/s12016-021-08875-0.
- Elmas ÖF, Akdeniz N, Atasoy M, et al. Contact dermatitis: a great imitator. Clin Dermatol. 2020;38(2):176–192. doi: 10.1016/j.clindermatol.2019.10.003.
- Hollins LC, Flamm A. Occupational contact dermatitis: evaluation and management considerations. Dermatol Clin. 2020;38(3):329–338. doi: 10.1016/j.det.2020.02.001.
- Geizhals S, Lipner SR. Review of onychocryptosis: epidemiology, pathogenesis, risk factors, diagnosis and treatment. Dermatol Online J. 2019;25(9):13030/qt9985w2n0.
- Mayeaux EJ, Carter C, Murphy TE. Ingrown toenail management. Am Fam Physician. 2019;100(3):158–164.
- Şenel E, Doğruer Şenel S, Salmanoğlu M. Prevalence of skin diseases in civilian and military population in a Turkish military hospital in the central black sea region. J R Army Med Corps. 2015;161(2):112–115. doi: 10.1136/jramc-2014-000267.
- Stewart CR, Algu L, Kamran R, et al. Patient satisfaction with treatment for onychocryptosis: a systematic review. Skin Appendage Disord. 2020;6(5):272–279. Sepdoi: 10.1159/000508927.
- Schissel DJ, Barney DL, Keller R. Cold weather injuries in an arctic environment. Mil Med. 1998;163(8):568–571. doi: 10.1093/milmed/163.8.568.
- Mendes B, Salomé GM, Pinheiro FAM, et al. Preventing and treating trench foot: validation of an educational manual for military personnel. J Wound Care. 2018;27(Suppl 10):S33–S38. doi: 10.12968/jowc.2018.27.Sup10.S33.
- Connor RR. Update: cold weather injuries, active and reserve components. U.S. Armed Forces, July 2009-June 2014. MSMR. 2014;21(10):14–19.
- Kowtoniuk RA, Liu YE, Jeter JP. Cutaneous cold weather injuries in the US military. Cutis. 2021;108(4):181–184. doi: 10.12788/cutis.0363.
- Hefazi M, Maleki M, Mahmoudi M, et al. Delayed complications of sulfur mustard poisoning in the skin and the immune system of Iranian veterans 16-20 years after exposure. Int J Dermatol. 2006;45(9):1025–1031. doi: 10.1111/j.1365-4632.2006.03020.x.
- Patterson AT, Kaffenberger BH, Keller RA, et al. Skin diseases associated with agent orange and other organochlorine exposures. J Am Acad Dermatol. 2016;74(1):143–170. Jandoi: 10.1016/j.jaad.2015.05.006.
- Contestable JJ. Jet Fuel-Associated occupational contact dermatitis. Mil Med. 2017;182(3):e1870–e3. doi: 10.7205/MILMED-D-16-00217.
- Daniele DO, Taubman SB. Update: plant dermatitis among active component service members, U.S. Armed Forces, 2010-2020. MSMR. 2021;28(11):11–14.
- Geretto M, Ferrari M, De Angelis R, et al. Occupational exposures and environmental health hazards of military personnel. Int J Environ Res Public Health. 2021;18(10):5395.
- Shin H, Kim DH, Ryu HH, et al. Teledermatology consultation using a smartphone multimedia messaging service for common skin diseases in the Korean army: a clinical evaluation of its diagnostic accuracy. J Telemed Telecare. 2014;20(2):70–74. Mardoi: 10.1177/1357633X14524151.
- Klaz I, Wohl Y, Nathansohn N, et al. Teledermatology: quality assessment by user satisfaction and clinical efficiency. Isr Med Assoc J. 2005;7(8):487–490.
- Hwang JS, Lappan CM, Sperling LC, et al. Utilization of telemedicine in the U.S. military in a deployed setting. Mil Med. 2014;179(11):1347–1353. doi: 10.7205/MILMED-D-14-00115.
- Petrova E, Farinholt T, Joshi TP, et al. A community-based management of COVID-19 in a mobile container unit. Vaccines. 2021;9(11):1362. doi: 10.3390/vaccines9111362.